|
FAM82A2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36140000384088E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.91610002811638E-09 |
| Normal-vs-Stage2 |
1.248500E-04 |
| Normal-vs-Stage3 |
2.381400E-03 |
| Normal-vs-Stage4 |
2.140000E-02 |
| Stage1-vs-Stage2 |
3.968000E-01 |
| Stage1-vs-Stage3 |
6.184400E-01 |
| Stage1-vs-Stage4 |
5.005000E-01 |
| Stage2-vs-Stage3 |
8.719600E-01 |
| Stage2-vs-Stage4 |
4.007200E-01 |
| Stage3-vs-Stage4 |
4.457000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.87839996071915E-09 |
| Normal-vs-AfricanAmerican |
3.438400E-04 |
| Normal-vs-Asian |
4.135600E-01 |
| Caucasian-vs-AfricanAmerican |
2.849800E-01 |
| Caucasian-vs-Asian |
8.811600E-01 |
| AfricanAmerican-vs-Asian |
9.563200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.42339997963614E-09 |
| Normal-vs-Female |
4.836400E-04 |
| Male-vs-Female |
3.480200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.13329999999567E-05 |
| Normal-vs-Extreme_Weight |
7.5350999884094E-09 |
| Normal-vs-Obese |
3.647500E-04 |
| Normal-vs-Extreme_Obese |
4.094100E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.216000E-01 |
| Normal_Weight-vs-Obese |
4.634600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.471400E-01 |
| Extreme_Weight-vs-Obese |
2.622800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.319400E-01 |
| Obese-vs-Extreme_Obese |
7.237400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.35960000000346E-05 |
| Normal-vs-Age(41-60Yrs) |
3.81890000000773E-06 |
| Normal-vs-Age(61-80Yrs) |
1.65229999682381E-08 |
| Normal-vs-Age(81-100Yrs) |
3.799200E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.485200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.707000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.236000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.906400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.000200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.093800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.01230000049135E-07 |
| Normal-VS-Type2 PRCC |
2.224800E-04 |
| Normal-VS-KIRP CIMP |
2.04869999853585E-08 |
| Normal-VS-Unclassified PRCC |
8.01220000000713E-05 |
| Type1 PRCC-VS-Type2 PRCC |
4.348400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.276000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.814600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.685820E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.985400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.549600E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.22890000001197E-06 |
| Normal-vs-N1 |
1.405710E-04 |
| Normal-vs-N2 |
1.355160E-04 |
| N0-vs-N1 |
3.149400E-01 |
| N0-vs-N2 |
2.661600E-01 |
| N1-vs-N2 |
6.203600E-01 |
|
|
